Skip to main content

TCM clears big hurdle in US

By November 27, 2013News
tcm-china-image

tcm-china-image

A Chinese herbal medicine for liver ailments has cleared a big hurdle with regulators in the United States, but there’s still a long way to go.

For Tarek Hassanein, a professor of medicine at the University of California, San Diego School of Medicine, it took a long time to learn and finally to pronounce “fuzhenghuayu (FZHY)”. That’s the Chinese name of a patented Chinese drug that treats liver fibrosis, the scarring process of the liver from injuries and diseases.

{iframe}http://www.ecns.cn/business/2013/11-27/90119.shtml{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.